Get the Stockscreener App
0.816
0.21%
0.0017
Scynexis Inc stock is traded at $0.816, with a volume of 118.47K.
It is up +0.21% in the last 24 hours and up +14.93% over the past month.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
See More
Previous Close:
$0.8143
Open:
$0.8
24h Volume:
118.47K
Relative Volume:
0.62
Market Cap:
$34.21M
Revenue:
$3.26M
Net Income/Loss:
$-19.52M
P/E Ratio:
-2.04
EPS:
-0.4
Net Cash Flow:
$-24.10M
1W Performance:
-2.85%
1M Performance:
+14.93%
6M Performance:
-23.74%
1Y Performance:
-51.43%
1-Day Range:
$0.80
$0.82
1-Week Range:
$0.7826
$0.87
52-Week Range:
$0.66
$1.73
Scynexis Inc Stock (SCYX) Company Profile
Name
Scynexis Inc
Sector
Phone
201-884-5485
Address
1 EVERTRUST PLAZA, JERSEY CITY, NJ
Compare SCYX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SCYX
Scynexis Inc
|
0.816 | 33.64M | 3.26M | -19.52M | -24.10M | -0.40 |
|
ZTS
Zoetis Inc
|
156.62 | 67.51B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.52 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.82 | 43.42B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.46 | 20.72B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
312.23 | 14.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Scynexis Inc Stock (SCYX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-22-21 | Initiated | Guggenheim | Buy |
| Jan-06-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-11-18 | Upgrade | Needham | Hold → Buy |
| Jun-27-18 | Initiated | Maxim Group | Buy |
| Oct-24-17 | Initiated | Guggenheim | Buy |
| Jul-10-17 | Initiated | ROTH Capital | Buy |
| May-09-17 | Downgrade | Needham | Buy → Hold |
| Mar-03-17 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-20-16 | Initiated | H.C. Wainwright | Buy |
| Oct-07-16 | Upgrade | WBB Securities | Buy → Strong Buy |
| Oct-03-16 | Resumed | Brean Capital | Buy |
| Aug-17-16 | Initiated | Guggenheim | Buy |
| Aug-09-16 | Reiterated | Needham | Buy |
| Aug-09-16 | Upgrade | WBB Securities | Speculative Buy → Buy |
| Mar-28-16 | Initiated | Brean Capital | Buy |
| Dec-29-15 | Initiated | WBB Securities | Speculative Buy |
| Nov-16-15 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-10-15 | Initiated | Needham | Buy |
| May-29-14 | Initiated | Canaccord Genuity | Buy |
| May-29-14 | Initiated | RBC Capital Mkts | Outperform |
View All
Scynexis Inc Stock (SCYX) Latest News
SCYNEXIS Inc. stock trend forecast2025 Analyst Calls & Real-Time Chart Breakout Alerts - Newser
Using Python tools to backtest SCYNEXIS Inc. strategiesJuly 2025 Market Mood & High Yield Equity Trading Tips - Newser
Will earnings trigger a reversal in SCYNEXIS Inc.Market Weekly Review & Weekly Chart Analysis and Trade Guides - Newser
Backtesting results for SCYNEXIS Inc. trading strategiesTrade Performance Summary & Community Verified Watchlist Alerts - Newser
How to escape a deep drawdown in SCYNEXIS Inc.Market Growth Summary & Long-Term Safe Investment Ideas - Newser
Historical volatility pattern of SCYNEXIS Inc. visualizedJuly 2025 Setups & Daily Volume Surge Trade Alerts - Newser
SCYNEXIS Inc. stock retracement – recovery analysisMarket Growth Summary & Real-Time Chart Breakout Alerts - Newser
Sector ETF performance correlation with SCYNEXIS Inc.Bull Run & Smart Allocation Stock Tips - Newser
Why SCYNEXIS Inc. stock attracts strong analyst attention2025 Dividend Review & Community Driven Trade Alerts - Newser
Top chart patterns to watch in SCYNEXIS Inc.Quarterly Trade Summary & Weekly Chart Analysis and Trade Guides - Newser
Price momentum metrics for SCYNEXIS Inc. explainedJuly 2025 Action & Weekly Return Optimization Alerts - Newser
Technical analysis overview for SCYNEXIS Inc. stockJuly 2025 Decliners & Verified Short-Term Plans - Newser
Bullish Candlestick Pattern Forms in SCYNEXIS Inc.Weekly Market Outlook & Weekly Sector Rotation Insights - metrotimes.co.kr
SCYNEXIS Reports Improved Financials Amidst Strategic Developments - MSN
RSI + MACD Show Convergence for SCYNEXIS Inc.2025 Key Highlights & Accurate Trade Setup Notifications - beatles.ru
Scynexis Reports Q2 2025 Earnings Miss, But Market Reaction Shows Resilience - AInvest
What’s next for SCYNEXIS Inc. stock priceJuly 2025 Trends & Low Risk Growth Stock Ideas - Newser
What candlestick patterns are forming on SCYNEXIS Inc.Quarterly Performance Summary & Fast Entry and Exit Trade Plans - Newser
Can SCYNEXIS Inc. hit a new high this monthMarket Performance Recap & Reliable Breakout Forecasts - Newser
SCYNEXIS Gets Boost from Maxim Group Analyst, Maintains Buy Rating and $4 Price Target - AInvest
Maxim Group Maintains Scynexis(SCYX.US) With Buy Rating, Maintains Target Price $4 - 富途牛牛
Real time scanner hits for SCYNEXIS Inc. explainedQuarterly Profit Summary & Weekly High Conviction Ideas - Newser
Optimistic Outlook on SCYNEXIS: Strategic Developments and Financial Health Drive Buy Rating - TipRanks
Is SCYNEXIS Inc. stock poised for growth2025 Winners & Losers & Safe Swing Trade Setup Alerts - Newser
Scynexis reports Q2 EPS (14c), consensus (19c) - MSN
Scynexis Posts Q2 2025 Earnings Miss; Market Resilience Observed Post-Report - AInvest
Key metrics from SCYNEXIS Inc.’s quarterly dataWeekly Profit Report & Expert Curated Trade Setup Alerts - Newser
Will a bounce in SCYNEXIS Inc. offer an exit2025 Pullback Review & Long Hold Capital Preservation Tips - Newser
SCYNEXIS Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Scynexis 2025 Q2 Earnings Significant Loss Reduction - AInvest
How high can SCYNEXIS Inc. stock goPrice Action & Growth Focused Investment Plans - Newser
Scynexis Inc Stock (SCYX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.37%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):